JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
24/10/2024
0:00
20:41
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:
Altri episodi di "JAMA Network"
Non perdere nemmeno un episodio di “JAMA Network”. Iscriviti all'app gratuita GetPodcast.